TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CARA
Shares outstanding
9,346,119
Price per share
$4.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
22,165
Total reported value
$862,745
% of total 13F portfolios
0%
Share change
+236
Value change
+$8,201
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sporos Bioventures LLC 9% $19,544,812 837,636 Sporos Bioventures LLC 15 Apr 2025
Solas Tvardi Sidecar LLC 8.1% $4,050,047 761,287 Solas Tvardi Sidecar LLC 15 Apr 2025
Tweardy David John 7% $3,470,757 652,398 David J. Tweardy 15 Apr 2025
DePinho Ronald A 6.7% -20% $24,413,770 -$6,035,311 626,190 -20% Ronald A. DePinho 30 Sep 2025
Tweardy Samuel David 3.4% -67% $7,365,343 -$14,730,686 315,658 -67% Samuel D. Tweardy 07 Jul 2025

As of 30 Sep 2025, 8 institutional investors reported holding 22,165 shares of TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA). This represents 0.24% of the company’s total 9,346,119 outstanding shares.

Institutional Holders of TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 127 $546 +$546 $4.30 1
2025 Q3 22,165 $862,745 +$8,201 $39.00 8
2025 Q2 21,929 $511,606 -$2,705,206 $23.33 7
2025 Q1 633,363 $3,211,465 -$2,599,722 $5.07 33
2024 Q4 1,075,203 $6,580,102 +$6,496,611 $6.12 39
2024 Q3 250 $77 +$77 $0.31 1